ACTU
Actuate Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$2.56
+0.01 ▲ +0.39%
🌙 3월 13일 4:10 PM ET (한국 3/14 05:10)
$2.56
+0.00 +0.00%
| Index | RUT | P/E | - | EPS (ttm) | -1.21 | Insider Own | 58.27% | Shs Outstand | 0.02B | Perf Week | -10.49% |
| Market Cap | 0.06B | Forward P/E | - | EPS next Y | -26.91% | Insider Trans | -2.03% | Shs Float | 0.01B | Perf Month | -39.34% |
| Enterprise Value | 0.04B | PEG | - | EPS next Q | -0.25 | Inst Own | 13.18% | Short Float | 6.61% | Perf Quarter | -66.32% |
| Income | -0.02B | P/S | - | EPS this Y | 9.06% | Inst Trans | 5.06% | Short Ratio | 8.76 | Perf Half Y | -63.22% |
| Sales | 0.00B | P/B | 5.44 | EPS next 5Y | -4.61% | ROA | -150.86% | Short Interest | 0.64M | Perf YTD | -58.17% |
| Book/sh | 0.47 | P/C | 3.52 | EPS past 3/5Y | -15.08% - | ROE | -296.04% | 52W High | -78.65% ($11.99) | Perf Year | -65.64% |
| Cash/sh | 0.73 | P/FCF | - | Sales past 3/5Y | - | ROIC | -212.67% | 52W Low | 9.87% ($2.33) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 17.97% | Gross Margin | - | Volatility(W/M) | 14.27% 11.82% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.4 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 2.74 | EPS Q/Q | 17.34% | Profit Margin | - | RSI (14) | 23.87 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.74 | Sales Q/Q | - | SMA20 | -27.08% ($3.51) | Beta | 0.79 | Target Price | $25 |
| Payout | - | Debt/Eq | 0.04 | Earnings | 2026/02/25 | SMA50 | -44.25% ($4.59) | Rel Volume | 1.65 | Prev Close | $2.55 |
| Employees | 10 | LT Debt/Eq | 0.04 | EPS/Sales Surpr. | -0.86% - | SMA200 | -61.22% ($6.6) | Avg Volume(3M) | 0.07M | Price | $2.56 |
| IPO | 2024/8/13 | Option/Short | No/Yes | Trades | 703 | Volume | 120,715 | Change | 0.39% |
뉴스 로딩 중...